Healthcare Pharmaceutical Biotech

HonorBridge Named a Best Employer in North Carolina for Sixth Year in a Row

June 2, 2026 10:25 AM

HonorBridge has once again been named one of the Best Employers in North Carolina by Business North Carolina magazine, marking the sixth consecutive year the organization has received this recognition. The honor reflects HonorBridge's continuous commitment to cultivating a strong workplace culture in support of its lifesaving mission. As North Carolina's largest organ donation and tissue recovery organization, HonorBridge connects donors with...

Read more

2026 Top Client-Rated Payer IT Vendors Across 27 Managed Care Technology Categories Named in Black Book User Surveys

June 2, 2026 9:25 AM

Black Book Research today announced the 2026 top client-rated payer IT vendors from its annual State of Payer Digital Technology: Managed Care and Health Plans study, identifying #1 client satisfaction leaders across payer software, platform, managed services, BPaaS, outsourcing and technology-enabled operating categories. The 2026 findings show payer technology buying moving away from broad enterprise software comparisons and toward accountable...

Read more

Black Book Polls Find Health Plans Moving From Digital Transformation Promises to Proof-Based Payer IT Execution

June 2, 2026 9:10 AM

Black Book Research announced new findings from its 2026 State of Payer Digital Technology report now, revealing that U.S. health plans and managed care organizations are entering a more disciplined payer IT buying cycle defined by measurable execution, not broad digital transformation messaging. Based on polling of 8,194 verified health plan, managed care, payer technology, operations and services users, Black Book found that payer buyers are...

Read more

TeleTracking Brings Real-Time Operational Intelligence Beyond the Hospital Walls with Operations IQ(R) Ambulatory

June 2, 2026 9:03 AM

TeleTracking Technologies, the gold standard in healthcare operations technology, today announced a landmark expansion of its Operations IQ® Platform with the introduction of Operations IQ® Ambulatory - a powerful new pillar purpose-built to transform outpatient access and referral management across health systems. Building on the momentum of TeleTracking's strategic partnership with Palantir and the power of Foundry's data integration...

Read more

CVS Health Study Reveals a Need for Greater Digital Health Literacy for Medicare Members

June 2, 2026 9:00 AM

Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) released "Navigating the Digital Health Literacy Gap," a research-based white paper revealing a significant gap between older Americans' current ability to navigate digital health tools and their interest and openness to learning more. These findings come at a crucial time as health care undergoes a profound transformation fueled by AI just as all baby boomers will be age...

Read more

ZetrOZ Systems and National Foundations Partner to Expand Research and Access to New, Evidence-Based Healthcare

June 2, 2026 9:00 AM

ZetrOZ Systems, inventor of sustained acoustic medicine and the sam® wearable ultrasound device (sam), has extended and expanded partnerships with medical foundations and national advocacy groups to increase awareness and access to its proven treatment for soft-tissue injuries. The sam® wearable ultrasound device is revolutionary therapeutic technology cleared by the U.S. Food & Drug Administration for prescription home use, designed to treat...

Read more

Alpha Genesis Now Offers African Green Monkeys for Biomedical Research

June 2, 2026 9:00 AM

Alpha Genesis, Inc., America's leading provider of nonhuman primate research services, today announced that it now offers African green monkeys (Chlorocebus) as part of its expanding nonhuman primate research portfolio. The addition strengthens Alpha Genesis' ability to support biomedical research programs requiring scientifically valuable, flexible, and cost-effective nonhuman primate models. African green monkeys are an established and...

Read more

Moderna to Present at Upcoming Conference in June 2026

June 2, 2026 7:00 AM

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference: Goldman Sachs 47th Annual Global Healthcare Conference 2026, on Tuesday, June 9th at 3:20 p.m. ET A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna's website for at least 30...

Read more

MMJ International Holdings Joins Legal Challenge to Trump's Cannabis Rescheduling Order

June 2, 2026 3:40 AM

A federally compliant pharmaceutical cannabinoid developer has joined a coalition challenging the Trump administration's landmark cannabis rescheduling order, arguing the new regulatory framework creates a competitive disadvantage for companies that spent years and millions of dollars pursuing the traditional FDA approval pathway. MMJ International Holdings, (MMJ), a private pharmaceutical cannabinoid development company and parent of MMJ...

Read more

Evotec Appoints Rui Wang as Head of Global In Silico and AI

June 2, 2026 1:45 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the appointment of Rui Wang as Executive Vice President, Head of Global In Silico and AI. Mr. Wang brings to Evotec more than 20 years of experience supporting global pharma and biotech organizations to embed scalable data, analytics & AI across R&D, drug development, manufacturing and supply chain functions. In his role, Mr. Wang will spearhead the integration of computational...

Read more

MMJ International Holdings Joins Landmark D.C. Circuit Challenge to DEA's Marijuana Rescheduling Order

June 1, 2026 7:05 PM

MMJ International Holdings, MMJ BioPharma Cultivation, and MMJ BioPharma Labs, announced today that they have joined a Petition for Review filed in the United States Court of Appeals for the District of Columbia Circuit challenging the Drug Enforcement Administration's marijuana rescheduling order. The petition seeks judicial review of DEA's April 2026 Final Order that moved FDA approved marijuana products and state licensed medical marijuana...

Read more

Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026

June 1, 2026 4:15 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that it will be participating in a Fireside Q&A hosted by Lake Street Capital Markets at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub on Wednesday, June 17, 2026, at 10:30 a.m....

Read more

From Elite Athletes to Everyday Professionals: How ALYZE Is Making World-Class Coordinated Health Care Available for the First Time

June 1, 2026 3:50 PM

Inside a professional sports organization, health is never managed in pieces. Every person on the medical and performance staff knows what the others have found. A training load is adjusted because the bloodwork said to. A recovery protocol is changed because the diagnostics showed it was not working. Every decision is connected to every other decision, and the system holds itself accountable for producing results. For everyone outside that...

Read more

Scientists and Policy Experts to Brief Congress on FDA's 7-OH Action, Kratom, and Consumer Protection Legislation

June 1, 2026 12:23 PM

Nearly a year after the FDA recommended in July 2025 that the DEA schedule synthetic 7-Hydroxymitragynine (7-OH) - drawing a clear line between concentrated synthetics and natural kratom plant products - there is still no federal legislation, guidance, or coherent policy to back it up, leaving state legislators confused and pursuing conflicting directives. The American Kratom Association (AKA) will host a Congressional Briefing to cut through...

Read more

Dr. Todd H. Lanman Presented Alignment-Driven Synergy Disc(R) Results and Case Experience at the 2nd Annual Hoag Orthopedic Institute Spine Symposium

June 1, 2026 11:45 AM

Todd H. Lanman, MD, FACS, FAANS, founder of Lanman Spinal Neurosurgery and ADR Spine, presented "Alignment-Driven Cervical Arthroplasty: Techniques, Case Experiences & Results with the Synergy Disc®" on Friday, May 29, at the 2nd Annual Hoag Orthopedic Institute Spine Symposium in Newport Beach, California. The presentation highlighted statistically superior 24-month outcomes from the FDA-approved Synergy Disc® 1-level IDE trial, along with...

Read more

From Fusion to Motion: Dr. Joel S. Beckett Presented Restorative Motion Surgery Concepts at the Hoag Orthopedic Institute Spine Symposium

June 1, 2026 11:40 AM

Joel S. Beckett, MD, MHS, FAANS, presented "From Fusion to Motion" on Friday, May 29th, at the 2nd Annual Hoag Orthopedic Institute Spine Symposium in Newport Beach, California. The presentation examined restorative motion surgery and the expanding role of cervical disc arthroplasty for select patients with persistent pain or pseudoarthrosis following anterior cervical discectomy and fusion (ACDF). Dr. Beckett discussed restorative motion...

Read more

IAVI to Advance Vaccine Candidate for Bundibugyo Virus, Receives Funding from CEPI

June 1, 2026 10:30 AM

IAVI, a global nonprofit biomedical research organization, today announced that it has reached an agreement with The University of Texas Medical Branch (UTMB) allowing IAVI to develop a recombinant vesicular stomatitis virus (rVSV)-based vaccine candidate targeting Bundibugyo virus (BDBV), the orthoebolavirus responsible for the ongoing Ebola epidemic in the Democratic Republic of the Congo (DRC) and Uganda. Also today, CEPI, a global...

Read more

Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and Interface Design

June 1, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), ("MDCE" or the "Company") a technology company focused on AI-powered imaging and wellness applications, today provided additional details regarding the user experience and interface design objectives currently being incorporated into the MDCE Melanoma Scan Beta platform. Building upon the Company's previously disclosed body-map monitoring architecture, current development efforts have...

Read more

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

June 1, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced the expansion of its Acute Kidney Injury (AKI) Advisory Board, with the addition of two new members, Dr. Peter Pickkers and Dr. Lui Forni, ahead of its upcoming Phase 2/3 clinical trial. The distinguished panel comprises internationally recognized...

Read more

CVS Health: Helping Seniors Navigate Digital-First Health Care

June 1, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Key points Many older adults struggle with digital health literacy, making everyday health tasks harder as digital-first care becomes more common. Seniors face real barriers to digital care, but they're eager to learn and want tools and experiences designed with them in mind. CVS Health is already taking meaningful steps to close the digital divide and make care simpler and more accessible for...

Read more